News

Prolira news

Prolira secures new investment round

Prolira develops the DeltaScan, which enables better and earlier detection of delirium. This way the patient receives necessary treatment timely. Oost NL as fund manager of Topfonds Gelderland, together with Holland Venture and Health Innovations, invested in Prolira. The investment enables further development and commercialization of DeltaScan.
The Dutch press release can be read by clicking on the logo’s/ picture above.

read more

Other news

Characteristics, Risk Factors And Outcome Of Early-Onset Delirium In Elderly Patients With First Ever Acute Ischemic Stroke - A Prospective Observational Cohort Study

Emergency Room Hallway Breeds Delirium

“The worst possible place for people at risk”

What to know about delirium

Delirium is a sudden change in a person’s mental function, which includes their ways of thinking and their behavior or level of consciousness. This change often affects memory and concentration.

Prolira B.V.
Padualaan 8
3584 CH, Utrecht
The Netherlands

 

T. +31 (0)85 06 01 656
E. Info@prolira.com
W. www.prolira.com